FY27 revenue target of ₹400 crore
Management expects revenue to reach ~₹400 crore in FY27, driven by Sterport capacity doubling and SVP expansion, implying ~33% YoY growth.
AMANTA / guidance tracker
Keep management guidance in view.
Amanta Healthcare · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
Sterport incremental revenue of ₹120 crore
The new Sterport line is expected to generate incremental revenue of ₹120 crore (plus/minus 4-5%) once fully ramped.
Overall EBITDA margin expansion of 3-4% post Sterport commissioning
Post Sterport capacity commissioning, overall company EBITDA margin is expected to expand by 3-4 percentage points to ~26-27%.
Debt reduction of ₹35-40 crore per annum
Management plans to repay ₹35-40 crore of debt annually from cash flows, reducing total debt from ~₹190 crore to ~₹150 crore by FY27 end.